Isomorphic and Eli Lilly Partner To Discover Molecule Therapeutics

Isomorphic Labs, a digital biology company with a mission to redefine drug discovery through the power of artificial intelligence, has announced a strategic research collaboration with Eli Lilly, an American pharmaceutical company headquartered in...

Aptar Digital and Gerresheimer Partner To Aid Patients in Cancer therapy

The innovative systems and solutions provider Gerresheimer, a global partner to the pharmaceutical, biotech, and cosmetics industries, and Aptar Digital Health, a leader in software as a medical device (SaMD), digital patient support programs...

US FDA Nods Pfizer & Genmab's Treatment For Cervical Cancer

The supplemental Biologics License Application (sBLA), filed on behalf of Pfizer Inc. and Genmab A/S, aims to convert the accelerated approval of Tivdak (tisotumab vedotin-tftv) to full approval for the treatment of patients with recurrent or...

Akumentis Healthcare Unveils Drug For Treatment of Epilepsy

Akumentis Healthcare Limited has launched Clasepi to combat epilepsy-related issues. Clasepi, a DCGI-approved prescription cannabidiol (CBD), is specifically developed to treat seizures caused by Lennox-Gastaut Syndrome (LGS), Dravet Syndrome, or...

India To Demand Quick Inspection of Pharma Companies By USFDA

At the Trade Policy Forum (TPF) meeting, India will strongly demand that the American health regulator expedite its USFDA inspections or audits of domestic pharmaceutical firms, lift the export ban on wild caught shrimp, and raise the issue of...

Transgene and NEC extend Pact For Clinical Development of Cancer Vaccine

Transgen announced that they have signed an additional development cooperation agreement for personalized interventions. neoantigen cancer vaccine TG4050. TG4050 is currently being evaluated in a randomized multicenter phase I trial as a single...

Molecule AI Introduces Molecule GEN For AI-driven Drug Discovery

Molecule AI, a pathfinder at the intersection of artificial intelligence and life sciences, today announces the debut of Molecule GEN, a game-changing platform destined to change AI-powered drug development. This disruptive Software-as-a-Service...

Isomorphic Labs Inks Pact with Novartis For Small Molecule Therapeutics

Isomorphic Labs, a digital biology firm on a goal to transform drug discovery through the use of artificial intelligence, announced a strategic research cooperation with Novartis to identify small molecule therapies against three undisclosed...

Drug Maker Novartis in Advanced Talks To Acquire Cytokinetics

Novartis, a Swiss drugmaker, is reportedly in advanced talks to acquire Cytokinetics, an American biotechnology business. Novartis is anticipated to win the Cytokinetics auction, beating out competitors such as AstraZeneca and Johnson...

Cipla To Partner With Kemwell Biopharma, Manipal Med Group To Form JV

Cipla Ltd, a prominent pharmaceutical company, has formed a joint venture in the United States with Kemwell Biopharma and Manipal Education & Medical Group to develop and commercialise innovative cell therapy products...

© 2024 India Pharma Outlook. All Rights Reserved.